CHAIRMAN: DR. KHALID BIN THANI AL THANI
EDITOR-IN-CHIEF: PROF. KHALID MUBARAK AL-SHAFI

World / Americas

AstraZeneca says COVID-19 vaccine trial in U.S still on hold

Published: 20 Sep 2020 - 11:04 am | Last Updated: 15 Nov 2021 - 08:45 am
FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange (NYSE) in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo

Reuters

AstraZeneca Plc AZN.L said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

AstraZeneca on Saturday published a document describing details of how the COVID-19 vaccine trial was being carried out, which was first reported by the New York Times.